Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank31
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-93.97M
↑ 15% vs avg
Percentile
P31
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-109.93M
Historical baseline
PeriodValueYoY Change
TTM$-93.97M+22.5%
2024$-121.31M+37.8%
2023$-195.10M-8.4%
2022$-179.91M-179.0%
2021$-64.49M+26.8%
2020$-88.13M-22.6%
2019$-71.88M+28.3%
2018$-100.28M-9.7%
2017$-91.39M+1.6%
2016$-92.84M-